BMY logo

BMY

Bristol-Myers Squibb Company

$59.60
$0.00(0.00%)
59
Overall
90
Value
45
Tech
44
Quality
How is this score calculated?
Market Cap
$123.83B
Volume
14.75M
52W Range
$42.52 - $62.89
Target Price
$62.50

Latest News for BMY

Bristol-Myers Squibb (BMY) Receives a Hold from Wells Fargo
TipRanks Auto-Generated Intelligence Newsdesk5 days agoApr 01, 2026

In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Bristol-Myers Squibb, with a price target of $60.00. Bansal c......

The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
Ran Melamed8 days agoMar 29, 2026

Markets React to Oil, Risk, and Rotation U.S. stocks moved lower last week as war risk and rising oil prices weighed on sentiment. The S&P 500 (SPX......

Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
TipRanks Clinical-Trials-Auto-Generated Newsdesk20 days agoMar 17, 2026

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) is running a Phase 1 study ......

Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
TipRanks Clinical-Trials-Auto-Generated Newsdesk20 days agoMar 17, 2026

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) is running a Phase 1 study ......

BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
TipRanks Clinical-Trials-Auto-Generated Newsdesk24 days agoMar 13, 2026

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb (BMY) is running a real-world chart r......

Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY)
Catie Powers24 days agoMar 13, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Korro Bio (KRRO – Research Report), Sagimet Biosci......

Bristol-Myers Squibb Tracks Real-World Impact of KarXT in Schizophrenia
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoMar 06, 2026

Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. The Bristol-Myers Squibb study “Effectiveness and Adverse-......

News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.

ABCD
1SymbolPriceChangeVol
2BMY$59.600%14.75M
3
4
5
6

Get Bristol-Myers Squibb Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.